Key facts
- SiVIEW’s last known valuation is $25.6M (Jan 2025).
- It has raised $11.7M; the latest was Later Stage VC ($5.2M) in Jan 2025.
- Notable investors include LBO France, Leia Capital.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for SiVIEW
- ·The full record, as it builds
Funding rounds
No funding rounds for SiVIEW are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About SiVIEW
Developer of a visual diagnostic device designed to offer personalized eye examinations for each patient. The company's devices utilize artificial intelligence, which allows for quick and easy examination of the eye, which is both precise and detailed, to be performed intuitively to support diagnosis and prescription, enabling healthcare professionals to focus on the patient and optimize the overall care plan.
- Sector
- Healthcare
- HQ
- Paris, France
- Founded
- 2016
- Employees
- 44
- Website
- siview.ai/
- Ownership
- Privately Held (backing)
SiVIEW doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in SiVIEW shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on SiVIEW in its N-PORT filings yet. We sweep new filings monthly.